MedTrace Logo

Blood Glycan Biomarkers in Women With Stage IV Breast Cancer

NCT00897962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2018-12-26

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood glycan biomarkers in women with stage IV breast cancer.

Conditions

Interventions

OTHER

Healthy Controls

One blood draw (2 teaspoons)

OTHER

Metastatic Breast Cancer

Blood samples will be drawn every 3 months, for up to 18 months.

OTHER

Non-cancer medical illness

One blood draw (2 teaspoons)

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Helen K. Chew, MD · University of California, Davis

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2011-02-28
Completion
2016-01-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897962 on ClinicalTrials.gov